Background: The purpose of the study was to investigate the potential influ
ence of the anaesthetic agent propofol on immune function in terms of syste
mic clearance and organ distribution of injected Escherichia coli in a rabb
it model.
Methods: Defined numbers of E. coli (1.3X10(8) colony-forming units, CFU) w
ere injected intravenously 1 h after starting a 4-h infusion of the anaesth
etic propofol (2 mi kg-l h-l, Disoprivan(R) 1%; n=6) or after saline applic
ation (n=6). As propofol is formulated in a 10% lipid emulsion, the lipid v
ehicle Intralipid(R) (2 ml kg(-1) h(-1); n=6) alone was investigated in a s
eparate group. Parameters monitored were arterial pressure and rates of bac
terial elimination from the blood. Three hours after bacterial injection, t
he animals were killed, and tissue samples of liver, spleen, lung, and kidn
ey were collected for microbiological examinations.
Results: Compared to saline-treated animals, infusion of propofol induced i
ncreased accumulation of E. coli in lung and spleen, thus reflecting reticu
loendothelial system dysfunction.
Conclusion: As the lipid emulsion by itself induced the same effects, the i
mpaired immune function due to propofol is thought to be attributed to its
solvent Intralipid(R).